Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TARA stock hub

Protara Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TARAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

290.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TARA

In the news

Latest news · TARA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-31.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-21.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TARA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001359931
Company name	Protara Therapeutics, Inc.
Country	United States
Country code	US
Cusip	74365U107
Employees	46
Employees Change	18%
Employees Change Percent	64.29
Enterprise value	$95.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US74365U1079
Last refreshed	2026-05-10
Market cap	$290.2M
Market cap category	Micro-Cap
Price	$5.27
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	TARA
Website	https://www.protaratx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.8%
FCF yield	-19.46%
P/B ratio	1.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-57.4M
Net Income Growth Years	0%
Profit Per Employee	$-1.2M
ROA	-20.64
Roa5y	-20.96
ROCE	-32.51
ROE	-31.6
Roe5y	-38.61
ROIC	-21.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	57.36%
Cagr3y	19.6%
Cagr5y	-11.72%
EPS Growth Quarters	7
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$209.5M
Cash	$155.6M
Current Assets	$159.5M
Current Liabilities	$10.9M
Debt	$3.4M
Debt Equity	$0.02
Equity	$196.4M
Liabilities	$13.1M
Long Term Assets	$50M
Long Term Liabilities	$2.1M
Net Cash	$194.5M
Net Cash By Market Cap	$67.04
Net Cash Growth	17.32%
Net Debt Equity	$-0.99
Tangible Book Value	$196.4M
Tangible Book Value Per Share	$3.67
WACC	12.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.58
Net Working Capital	$-5.7M
Quick ratio	14.34
Working Capital	$148.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-108.02%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	57.31%
200-day SMA	5.08
3Y total return	71.1%
50-day SMA	5.35
50-day SMA vs 200-day SMA	50over200
5Y total return	-46.39%
All Time High	67.08
All Time High Change	-92.14%
All Time High Date	2020-06-03
All Time Low	1.04
All Time Low Change	406.73%
All Time Low Date	2023-11-22
ATR	0.28
Beta	1.53
Beta1y	0.46
Beta2y	0.76
Ch YTD	-1.13
High	5.37
High52	7.82
High52 Date	2025-11-24
High52ch	-32.61%
Low	5.1
Low52	2.77
Low52 Date	2025-07-02
Low52ch	90.25%
Ma50ch	-1.55%
Premarket Change Percent	-1.3
Premarket Price	$5.3
Price vs 200-day SMA	3.74%
RSI	48.77
RSI Monthly	52.46
RSI Weekly	48.81
Sharpe ratio	0.92x
Sortino ratio	1.54
Total Return	-108.02%
Tr YTD	-1.13
Tr1m	2.53%
Tr1w	-0.94%
Tr3m	-20.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	3
Analyst Price Target Top	$24.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.37
Operating Income	$-64.5M
Price target	$24.4
Price Target Change	$363
Price Target Change Top	$368

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,410,439%
Float Percent	87.92%
Shares Insiders	1.92%
Shares Institutions	72.19%
Shares Out	55,060,500
Shares Qo Q	8.92%
Shares Yo Y	108.02%
Short Float	11.87%
Short Ratio	7.84
Short Shares	10.43

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-60.3M
Average Volume	622,251.75x
Bv Per Share	3.67
CAPEX	$-94,000
Ch1m	2.53
Ch1w	-0.94
Ch1y	57.31
Ch3m	-20.75
Ch3y	71.1
Ch5y	-46.39
Ch6m	22.84
Change	-1.86%
Change From Open	-1.31
Close	5.37
Days Gap	-0.56
Depreciation Amortization	362,000
Dollar Volume	3,349,453.9
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-64.5M
EBITDA	$-64.2M
EPS	$-1.34
F Score	1
FCF	$-56.5M
FCF EV Yield	-59.03x
FCF Per Share	$-1.03
Financing CF	82,715,000
Fiscal Year End	December
Investing CF	-139,491,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-10
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	5.66
Ma150ch	-6.94%
Ma20	5.27
Ma20ch	-0.02%
Net CF	-113,141,000
Next Earnings Date	2026-05-22
Open	5.34
Optionable	Yes
Position In Range	62.96
Post Close	5.27
Postmarket Change Percent	-0.19
Postmarket Price	$5.26
Ppne	3,933,000
Pre Close	5.37
Price Date	2026-05-08
Ptbv Ratio	1.48
Relative Volume	1.02x
Share Based Comp	3,826,000
Tr6m	22.84%
Us State	New York
Volume	635,570

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TARA pay a dividend?

Capital-return profile for this ticker.

Performance

TARA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TARA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+72.2%

Float: +87.9% of shares outstanding

Insider ownership

+1.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TARA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.8

Neutral momentum band

Price vs 200-day MA

+3.7%

50/200-day relationship not available

Beta (5Y)

1.53

More volatile than the market

Sharpe ratio

0.92

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TARA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TARA stock rating?

Protara Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TARA analysis?

The full report lives at /stocks/TARA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TARA?

The latest report frames TARA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TARA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.